NCT03899571View on ClinicalTrials.gov

Prophylactic Treatment With Oseltamivir

NACompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

January 22, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Influenza, Human
Interventions
DRUG

Oseltamivir Oral Capsule for 5 days post-exposure

Patients will receive oseltamivir for 5 days after last influenza exposure.

DRUG

Oseltamivir Oral Capsule for 10 days post-exposure

Patients will receive oseltamivir for 10 days after last influenza exposure.

Trial Locations (1)

Unknown

University Medical center Ljubljana, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER

NCT03899571 - Prophylactic Treatment With Oseltamivir | Biotech Hunter | Biotech Hunter